Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group. [electronic resource]
Producer: 19940922Description: 641-9 p. digitalISSN:- 0269-9370
- Acquired Immunodeficiency Syndrome -- complications
- Acyclovir -- administration & dosage
- Administration, Oral
- Adult
- Antiviral Agents -- therapeutic use
- Australia -- epidemiology
- Cytomegalovirus Infections -- complications
- Double-Blind Method
- Europe -- epidemiology
- Female
- Follow-Up Studies
- HIV Core Protein p24 -- blood
- Herpesviridae Infections -- complications
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Pneumonia, Pneumocystis -- epidemiology
- Proportional Hazards Models
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.